Abstract: The present invention is directed to methods and compositions for treating upper respiratory indications, such as the treatment, management or mitigation of cough, cold, cold-like symptoms, symptoms related to upper respiratory infections, influenza symptoms and allergic rhinitis, perennial rhinnitis, nasal and Eustachian tube congestion in an animal by administration of tannate compositions comprising combinations of at least one or more agents into a single administrative dose.

Abstract: A process is provided for preparing a low odor composition containing a dicyclopentenyl ester including the steps of preparing a distillation mixture containing the dicyclopentenyl ester and from 10 to 10,000 parts per million by weight based on weight of the dicyclopentenyl ester, of a suitable inhibitor; distilling the distillation mixture at a temperature in the range of 140° C. to 250° C.; collecting a first distillation fraction of the dicyclopentenyl ester; and then collecting a second distillation of the dicyclopentenyl ester; wherein the level of dicyclopentenyloxy(meth)acrylate in the second distillation fraction is in the range of 0 to 0.2 weight %, based on the weight of the dicyclopentenyl ester in the second distillation fraction. The second distillation fraction provides a low odor composition of the dicyclopentenyl ester which is useful as a reactive coalescent.

Abstract: A process for preparing alkyl acrylates is disclosed. The process provides for the synthesis of alkyl (meth)acrylates, hydrolysis of process impurities into starting materials and separation of starting materials and reaction products in one reactor.

Abstract: The invention relates to dendrimeric fullerene derivatives in which the fullerene is linked to at least one dendron, wherein the or each dendron has at least one protic group which imparts water solubility.

Abstract: The invention relates to six new crystal polymorphs, &agr; (alpha), &bgr; (beta), &ggr; (gamma), &dgr; (delta), &zgr; (zeta), and &eegr; (eta), of the disazo colorant of the formula I, having characteristic reflections in the X-ray diffraction spectrum. The novel crystal polymorphs are prepared by treatment in organic solvents.

Abstract: An amino acid derivative composition which comprises two or more kinds of amino acid derivatives represented by the general formula (1): wherein R's are the same or different and each represents a hydrogen atom or an alkyl group containing 1 to 18 carbon atoms; L1 represents —M1—X or —CHX—M2—X; L2 represents —CH2—M3—X or —CHX—M4—X; M1, M2, M3 and M4 are the same or different and each represents a straight or branched alkylene group containing 1 to 6 carbon atoms; X represents COOM; M's are the same or different and each represents a hydrogen atom, an alkali metal atom, an alkaline earth metal atom or an ammonium group; m represents an integer of 1 or 2 and n represents an integer of 0 or 1 on the condition that m+n is equal to 2 is provided.

Abstract: The invention is related to a flavorant composition containing 1′-acetoxychavicol acetate and 1′-acetoxyeugenol acetate derivatives thereof as well as a flavorant acceptable carrier. The flavorant composition may be used for flavoring foods, beverages or healthcare products with warm/hot, spicy and pungent sensations related to Galangal.

Abstract: Process for converting a nitrobenzene into a free aminophenol by catalytic reduction hydroxylation in the presence of an aqueous-acidic reaction medium.

Abstract: Compositions and methods are provided for prevention and treatment of cancer. The compositions comprise pure hydroxylated chalcone compounds of licorice root (Glycyrrhiza glabra) including 1-propanone-1-(2,4-dihydroxyphenyl)-3-hydroxy-3-(4′-hydroxyphenyl).

Abstract: The compounds are (+)- and (−)-2-cyclododecylpropanol and (+)- and (−)-2-cyclododecylpropionic acid, and salts thereof. (−)-2-cyclododecylpropanol is suitable as a fragrance while the virtually odorless (+) enantiomer is suitable as a fixative for other fragrances. The two enantiomers of 2-cyclododecylpropanol are prepared by reduction of the acid function of the enantiomers of 2-cyclododecylpropionic acid.

Abstract: A process produces sorbic acid or its salt and includes the step of retaining a slurry or solution containing sorbic acid or its salt while holding an oxygen concentration of a gaseous phase at 4% by volume or less, the gaseous phase being in contact with the slurry or solution containing sorbic acid or its salt. In the process, the oxygen concentration of the gaseous phase may be held at 4% by volume or less while introducing an inert gas into a gaseous phase of a reservoir holding the slurry or solution and/or of a conduit adjacent to the reservoir. Such an inert gases includes, for example, nitrogen gas. The oxygen concentration of the gaseous phase is preferably held at 1% by volume or less. The process can prevent the formation of new color-inducing substances in a purification operation of sorbic acid or its salt, and the obtained sorbic acid or its salt has a minimized degree of coloring and a minimized deterioration of hue over time.

Abstract: A process for production of carboxylic acid aryl esters which comprises reacting a carboxylic acid having at least one carboxyl group with a di- or tri-aryl phosphite compound, in the presence of a basic compound and/or water. The carboxylic acid aryl esters can also be produced by reacting a carboxylic acid or a basic salt thereof with a diaryl phosphite compound.

Abstract: The present invention provides 2-aminopyridine and 2-pyridone C-nucleosides and oligonucleotides containing the subject nucleosides. The nucleosides are useful in the preparation of the subject oligonucleotides. The oligonucleotides are useful in oligonucleotide-based diagnosis and separation through triplex binding.

Abstract: Crystals of [S,S]-ethylenediamine-N,N′-disuccinic acid which have a bulk density of 0.45 to 1.2 g/cm3, and a process for obtaining these crystals comprising the steps of adjusting an aqueous solution of an [S,S]-ethylenediamine-N,N′-disuccinic acid metal salt to a temperature of 40 to 80° C. and a pH of 1.9 to 4.5, and cooling the solution to a temperature below 40° C. over a period of 0.2 to 10 hours while supplying a mineral acid so as to maintain the pH at 1.9 to 4.5 to precipitate [S,S]-ethylenediamine-N,N′-disuccinic acid in a high yield.

Abstract: Inhibitors of the cytosolic phospholypase A2 enzymes are provided which are of use in controlling a wide variety of inflammatory diseases. The inhibitors of the present invention have the general formula where X, Z, X1, R1, R2, Ra and Rb are as defined in the specification.

Abstract: A method for producing carboxylic acid fluorides of the formula RCFXC(O)F, where X represents fluorine or chlorine, in good yields and with good selectivity for the carboxylic acid fluorides by reacting compounds of the formula RCFXCHFCl with oxygen by photochemical oxidation in the gaseous phase, preferably under sensitization with chlorine and using light having a wavelength &lgr;≧280 nm, which conditions make it possible to work without the use of pressure. Glass apparatus may be covered with a protective coating so as to protect it against traces of hydrogen fluoride. To this end, for example, heat-shrinkable sleeves made of light-permeable hydrogen fluoride-resistant material may be used. Polytetrafluoroethylene, polyfluoropropylene or a mixture thereof are especially suitable for this purpose.

Abstract: A method for producing 6,6-dialkoxy-5-hydroxy-3-oxo-hexanoic acid esters of general formula (I), wherein the dianion of an acetoacetic acid alkyl ester is reacted with an aldehyde. The 6,6-dialkoxy-5-hydroxy-3-oxo-hexanoic acid esters of general formula (I) are important synthesis building blocks for producing HMG-CoA-reductase-inhibitors.

Abstract: The invention comprises a novel lactate compound for two unique purposes: (1) cardiac energy resuscitation and the treatment or prevention of reperfusion injury following ischemia, and (2) the provision of a fuel energy source to humans and other mammals during exercise and recovery. The novel lactate compound is particularly a lactate thiolester. Preferably, the thiol is selected from a cysteine or a methionine amino acid. In a particularly preferred form, the compound is a lactate N-acetyl ethyl ester of the cysteine or methionine amino acid. The most preferred compound is lactate N-acetyl cysteine thiolester (LNACE): Further, the invention involves use of mixtures of lactate- and pyruvate compounds as well as hexoses (glucose and fructose), maltodextrins and electrolytes as adjutants to support LNACE in its specific purposes.

Abstract: The present invention relates to a process for the preparation of a carboxylic acid ester of the general formula II, wherein R is alkyl or aryl, R1 is aryl, substituted aryl, naphthyl or substituted naphthyl or alkyl, R2, R3, R4 and R5 are independently hydrogen or alkyl by reacting an olefin of the general formula I wherein, R1 is aryl, substituted aryl, naphthyl or substituted naphthyl or alkyl, R2, R3, and R4 are independently hydrogen or alkyl, in the presence of an alcohol and an organic solvent and a supported aqueous phase palladium complex catalyst, in presence or absence of a protonic acid and an alkali metal halide, under carbon monoxide atmosphere, cooling the reaction mixture to ambient temperature, depressurising the reactor, flushing the reaction vessel with inert gas, separating the catalyst by filtration and removing the solvent and isolating the compound of formula II.

Abstract: The invention concerns a method for phosgenation of monohydroxy alcohol's and/or polyols characterised in that it consists of treating alcohol and or polyol, whether in the presence of solvent or not, with a molar excess of phosgene, preferably 2 to 30 times more phosgene than the hydroxyl groups, at temperatures ranging between 0 and 200° C. and at pressure levels ranging between 2 and 60 bar, preferably in the absence of any catalyst. The method is further characterised in that pressure is further used to facilitate the separation of hydrochloric acid from phosgene, in a column external to the reactor.